Swiss National Bank Portfolio holdings
The Swiss National Bank (SNB), founded in 1907 and headquartered in Zurich with an office in Bern, is Switzerland’s central bank, responsible for conducting monetary policy, issuing the Swiss franc, and ensuring price stability, while uniquely managing a massive investment portfolio. Unlike most central banks, the SNB is a joint-stock company with shares traded on the SIX Swiss Exchange, owned roughly 55% by public entities like cantons and 45% by private investors, yet it operates independently under federal oversight. It holds over $800 billion in foreign currency reserves as of late 2024—invested in global equities, bonds, and gold—to manage the franc’s value, famously intervening in markets to prevent excessive appreciation, as seen with the 2015 abandonment of the euro peg. Led by Chairman Thomas Jordan until his planned exit in September 2024, the SNB balances its dual role as a monetary authority and a significant global investor, influencing both Swiss and international financial stability.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Dow Inc
DOW
|
+$132M |
| 2 |
Newmont
NEM
|
+$67.7M |
| 3 |
Corteva
CTVA
|
+$65.9M |
| 4 |
Amcor
AMCR
|
+$58.2M |
| 5 |
Alibaba
BABA
|
+$48.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
DuPont de Nemours
DD
|
+$128M |
| 2 |
Apple
AAPL
|
+$93M |
| 3 |
GG
Goldcorp Inc
GG
|
+$78.3M |
| 4 |
Microsoft
MSFT
|
+$73.5M |
| 5 |
Pfizer
PFE
|
+$52.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.91% |
| 2 | Healthcare | 14.68% |
| 3 | Consumer Discretionary | 11.95% |
| 4 | Communication Services | 10.15% |
| 5 | Industrials | 9.73% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
EXTN
2226
DELISTED
Exterran Corporation
EXTN
| $813K | ﹤0.01% |
57,150
-2,200
| -4% | -$32.3K |
|
2227
Waterstone Financial
WSBF
$370M
| $812K | ﹤0.01% |
47,600
+3,600
| +8% | +$59.8K |
|
|
HTB
2228
HomeTrust Bancshares
HTB
$826M
| $812K | ﹤0.01% |
32,300
| – | – |
|
2229
Donnelley Financial Solutions
DFIN
$1.17B
| $811K | ﹤0.01% |
60,804
-1,400
| -2% | -$19.8K |
|
2230
Rigel Pharmaceuticals
RIGL
$778M
| $809K | ﹤0.01% |
31,008
+3,050
| +11% | +$68.8K |
|
|
CBAY
2231
DELISTED
Cymabay Therapeutics
CBAY
| $808K | ﹤0.01% |
112,900
+2,300
| +2% | +$26K |
|
|
SWIR
2232
DELISTED
Sierra Wireless
SWIR
| $808K | ﹤0.01% |
66,800
| – | – |
|
|
RAD
2233
DELISTED
Rite Aid Corporation
RAD
| $805K | ﹤0.01% |
100,490
+3,300
| +3% | +$28.5K |
|
2234
Agilysys
AGYS
$3.02B
| $801K | ﹤0.01% |
+37,300
| New | +$774K |
|
2235
Vishay Precision Group
VPG
$864M
| $800K | ﹤0.01% |
+19,700
| New | +$746K |
|
|
ACBI
2236
DELISTED
Atlantic Capital Bancshares, Inc. Common Stock
ACBI
| $798K | ﹤0.01% |
46,600
-1,000
| -2% | -$17.5K |
|
|
QADA
2237
DELISTED
QAD Inc.
QADA
| $796K | ﹤0.01% |
19,800
+500
| +3% | +$22.3K |
|
2238
Live Oak Bancshares
LOB
$1.95B
| $794K | ﹤0.01% |
46,300
+1,000
| +2% | +$16.4K |
|
|
DERM
2239
DELISTED
Dermira, Inc.
DERM
| $793K | ﹤0.01% |
82,900
-1,800
| -2% | -$19.4K |
|
|
BGG
2240
DELISTED
Briggs & Stratton Corp.
BGG
| $791K | ﹤0.01% |
77,200
| – | – |
|
|
CHS
2241
DELISTED
Chicos FAS, Inc.
CHS
| $789K | ﹤0.01% |
234,000
+4,900
| +2% | +$17.8K |
|
|
SVM
2242
Silvercorp Metals
SVM
$2.7B
| $786K | ﹤0.01% |
317,900
+10,400
| +3% | +$23.9K |
|
|
OLP
2243
One Liberty Properties
OLP
$512M
| $785K | ﹤0.01% |
27,100
+600
| +2% | +$17.3K |
|
2244
American Vanguard Corp
AVD
$65.5M
| $784K | ﹤0.01% |
50,851
+1,100
| +2% | +$16.8K |
|
2245
Prothena Corp
PRTA
$468M
| $784K | ﹤0.01% |
74,200
+1,600
| +2% | +$16.4K |
|
|
UMH
2246
UMH Properties
UMH
$1.34B
| $783K | ﹤0.01% |
63,100
+1,300
| +2% | +$17.5K |
|
|
AKCA
2247
DELISTED
Akcea Therapeutics Inc
AKCA
| $781K | ﹤0.01% |
33,300
+800
| +2% | +$19.8K |
|
|
SPTN
2248
DELISTED
SpartanNash
SPTN
| $780K | ﹤0.01% |
66,880
+1,400
| +2% | +$20K |
|
2249
Astrana Health
ASTH
$1.86B
| $779K | ﹤0.01% |
46,644
| – | – |
|
|
MNTV
2250
DELISTED
Momentive Global Inc. Common Stock
MNTV
| $779K | ﹤0.01% |
+47,200
| New | +$806K |
|
Similar funds
Swiss National Bank's Q2 2019 Portfolio in Review
As of Q2 2019, Swiss National Bank held 2,619 positions worth $92.7B, up 1.7% from $91.2B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Swiss National Bank's Q2 2019 filing shows 112 new, 1,554 increased, 696 reduced and 65 closed positions. Its largest new stake was Dow Inc: 2,494,044 shares worth $123M. The largest sale was DuPont de Nemours, an estimated $128M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 20% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Swiss National Bank's largest Q2 2019 buy was Dow Inc: 2,494,044 shares worth $123M.
- Swiss National Bank added most to Newmont in Q2 2019, an estimated $67.7M increase.
- Swiss National Bank's biggest Q2 2019 reduction was DuPont de Nemours, cutting an estimated $128M.
- Swiss National Bank fully exited Goldcorp Inc in Q2 2019, selling an estimated $78.3M.
- Swiss National Bank's ten largest holdings make up 18% of its $92.7B portfolio in Q2 2019.
- Swiss National Bank opened 112 new positions and closed 65 in Q2 2019.
- Swiss National Bank's portfolio value rose 1.7% quarter-over-quarter to $92.7B.
Based on Swiss National Bank's 13F filing for Q2 2019, filed 2 Aug 2019.